Anhar Kamarudin

Ms. Anhar Kamarudin

MBBS

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2021 in Life
Verified
Journal Article
Open access
PDF file
MMM. B. Malarvili
M. B. Malarvili
MAMushikiwabeza Alexie
Mushikiwabeza Alexie
NDNadhira Dahari
Nadhira Dahari
AKAnhar Kamarudin
Anhar Kamarudin
In November 2019, the novel coronavirus disease COVID-19 was reported in Wuhan city, China, and was reported in other countries around the globe. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Strategies such as contact tracing and a vaccination program have been imposed to keep COVID-19 under control. Furthermore, a fast, noninvasive and reliable testing device is needed urgently to detect COVID-19, so that contact can be isolated and ringfenced before the virus spreads. Although the reverse transcription polymerase chain reaction (RT-PCR) test is considered the gold standard method for the diagnosis of SARS-CoV-2 infection, this test presents some limitations which cause delays in detecting the disease. The antigen rapid test (ART) test, on the other hand, is faster and cheaper than PCR, but is less sensitive, and may limit SARS-CoV-2 detection. While other tests are being developed, accurate, noninvasive and easy-to-use testing tools are in high demand for the rapid and extensive diagnosis of the disease. Therefore, this paper reviews current diagnostic methods for COVID-19. Following this, we propose the use of expired carbon dioxide (CO2) as an early screening tool for SARS-CoV-2 infection. This system has already been developed and has been tested on asthmatic patients. It has been proven that expired CO2, also known as capnogram, can help differentiate between respiratory conditions and, therefore, could be used to detect SARS-CoV-2 infection, as it causes respiratory tract-related diseases.

15 April 2024 in Research Square
Verified
Preprint
Open access
PDF file
MMM. B. Malarvili
M. B. Malarvili
SRSantheraleka Ramanathan
Santheraleka Ramanathan
RMRishya Manikam
Rishya Manikam
ARAhmad Adib Ramli
Ahmad Adib Ramli
RRRafi’uddin Radzi Ruslay
Rafi’uddin Radzi Ruslay
ATAina Amalina Ahmad Tarmizi
Aina Amalina Ahmad Tarmizi
The goal of the exhaled breath waveform used in ventilation monitoring is to improve COVID-19 illness detection. Using exhaled breath patterns to differentiate between COVID and non-COVID healthy individuals, an algorithm for valid exhaled breath waveform segmentation and feature computation is created to identify the COVID-19 infection. A two-minute exhaled breath pattern was recorded using a device and a nasal cannula sampling tube, resulting in the collection of exhaled breath waveforms from each subject. The developed algorithm is utilized to evaluate the valid exhaled breath waveforms and compute the features classified to distinguish between individuals who contracted COVID-19 infection and this who are healthy. Slope e2, activity e2 and intersection angle of expiration and inspiration phase showed p-value of 0.000, denoting the strong significance difference between COVID-19 patients and non-COVID healthy individuals. The statistical analyses revealed p-values of 0.039, 0.008, and 0.024 for area e2, mobility of e2 and complexity e3, indicating its significance in differentiating COVID-19 patients with non-COVID healthy individuals. The slope, area, and intersection angle as significant features showed good predictive power for compliance with p-value analysis with area under the receiver operating characteristic curve with 0.667, 0.693, and 0.775. Slope of e2, area of e2, intersection angle of expiration and inspiration phases are identified as the promising features to be chosen in discriminating COVID and non-COVID individuals. Trial registration: Clinical trial approval by Medical Research and Ethics Committee (MREC), 53 Malaysia, NMRR-21-763-59692. Registered 9th June 2021 and valid till 8th June 2023.